Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
1623: EFFECT OF ANGIOTENSIN II ON VASOPRESSOR DOSE AND SAFETY IN PATIENTS WITH SEVERE VASODILATORY SHOCK
QMRO Home
William Harvey Research Institute
Centre for Translational Medicine & Therapeutics
1623: EFFECT OF ANGIOTENSIN II ON VASOPRESSOR DOSE AND SAFETY IN PATIENTS WITH SEVERE VASODILATORY SHOCK
QMRO Home
William Harvey Research Institute
Centre for Translational Medicine & Therapeutics
1623: EFFECT OF ANGIOTENSIN II ON VASOPRESSOR DOSE AND SAFETY IN PATIENTS WITH SEVERE VASODILATORY SHOCK
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
1623: EFFECT OF ANGIOTENSIN II ON VASOPRESSOR DOSE AND SAFETY IN PATIENTS WITH SEVERE VASODILATORY SHOCK
Volume
47
Pagination
786 - 786
DOI
10.1097/01.ccm.0000552364.69876.25
Journal
Critical Care Medicine
ISSN
0090-3493
Metadata
Show full item record
Authors
Ferrada, P; Strumwasser, A; Zarbock, A; Mackey, C; Wilkinson, J; Handisides, D; Prowle, J
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/66435
Collections
Centre for Translational Medicine & Therapeutics
[915]